To evaluate erectile function (EF) and voiding function following primary targeted cryoablation of the prostate (TCAP) for clinically localized prostate cancer (CaP) in a contemporary cohort.
To evaluate erectile function (EF) and voiding function following primary targeted cryoablation of the prostate (TCAP) for clinically localized prostate cancer (CaP) in a contemporary cohort.
In Alberta, 1 in 6 men will be diagnosed with prostate cancer in their lifetime. When detected early, prostate cancer is one of the most successfully treated types of cancer.
The staff and volunteers at the Prostate Cancer Centre are dedicated to educating men about the importance of early detection.
